NO329526B1 - Tofunksjonelle molekyler inneholdende et peroksidderivat, fremgangsmate for fremstilling derav, anvendelse derav for fremstilling av antimalariaprodukter, samt farmasoytiske formuleringer som omfatter minst ett slikt koblingsprodukt - Google Patents

Tofunksjonelle molekyler inneholdende et peroksidderivat, fremgangsmate for fremstilling derav, anvendelse derav for fremstilling av antimalariaprodukter, samt farmasoytiske formuleringer som omfatter minst ett slikt koblingsprodukt Download PDF

Info

Publication number
NO329526B1
NO329526B1 NO20024795A NO20024795A NO329526B1 NO 329526 B1 NO329526 B1 NO 329526B1 NO 20024795 A NO20024795 A NO 20024795A NO 20024795 A NO20024795 A NO 20024795A NO 329526 B1 NO329526 B1 NO 329526B1
Authority
NO
Norway
Prior art keywords
mmol
formula
trioxane
preparation
citrate
Prior art date
Application number
NO20024795A
Other languages
English (en)
Norwegian (no)
Other versions
NO20024795D0 (no
NO20024795L (no
Inventor
Bernard Meunier
Anne Robert
Odile Dechy-Cabaret
Francoise Benoit-Vical
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Publication of NO20024795D0 publication Critical patent/NO20024795D0/no
Publication of NO20024795L publication Critical patent/NO20024795L/no
Publication of NO329526B1 publication Critical patent/NO329526B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
    • C07D323/04—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20024795A 2000-04-06 2002-10-04 Tofunksjonelle molekyler inneholdende et peroksidderivat, fremgangsmate for fremstilling derav, anvendelse derav for fremstilling av antimalariaprodukter, samt farmasoytiske formuleringer som omfatter minst ett slikt koblingsprodukt NO329526B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0004422A FR2807433B1 (fr) 2000-04-06 2000-04-06 Molecules duales contenant un derives peroxydique, leur synthese et leurs applications therapeutiques
PCT/FR2001/001013 WO2001077105A1 (fr) 2000-04-06 2001-04-04 Molecules duales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques

Publications (3)

Publication Number Publication Date
NO20024795D0 NO20024795D0 (no) 2002-10-04
NO20024795L NO20024795L (no) 2002-12-06
NO329526B1 true NO329526B1 (no) 2010-11-01

Family

ID=8848956

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024795A NO329526B1 (no) 2000-04-06 2002-10-04 Tofunksjonelle molekyler inneholdende et peroksidderivat, fremgangsmate for fremstilling derav, anvendelse derav for fremstilling av antimalariaprodukter, samt farmasoytiske formuleringer som omfatter minst ett slikt koblingsprodukt

Country Status (27)

Country Link
US (2) US6949569B2 (is)
EP (1) EP1268470B1 (is)
JP (1) JP2004521855A (is)
KR (1) KR100832047B1 (is)
CN (1) CN1193028C (is)
AP (1) AP1399A (is)
AR (1) AR041773A1 (is)
AT (1) ATE387441T1 (is)
AU (2) AU4846301A (is)
BR (1) BR0109885A (is)
CA (1) CA2405076C (is)
CY (1) CY1108071T1 (is)
DE (1) DE60132981T2 (is)
DK (1) DK1268470T3 (is)
ES (1) ES2302727T3 (is)
FR (1) FR2807433B1 (is)
HU (1) HUP0300428A2 (is)
IL (2) IL151918A0 (is)
IS (1) IS6579A (is)
MX (1) MXPA02009856A (is)
MY (1) MY128443A (is)
NO (1) NO329526B1 (is)
NZ (1) NZ521774A (is)
OA (1) OA13294A (is)
PT (1) PT1268470E (is)
WO (1) WO2001077105A1 (is)
ZA (1) ZA200207851B (is)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2862304A1 (fr) * 2003-11-14 2005-05-20 Centre Nat Rech Scient Molecules duales racemiques ou achirales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques
TW200728315A (en) * 2005-12-06 2007-08-01 Nippon Chemical Ind Phosphorus transition-metal complex, method of producing the same, and anticancer agent forming the same
FR2902100A1 (fr) * 2006-06-13 2007-12-14 Sanofi Aventis Sa Molecules duales contenant un derive peroxydique, leur synthese et leurs applications en therapeutique
FR2924343A1 (fr) * 2007-12-04 2009-06-05 Palumed Sa Nouvelles utilisations therapeutiques de molecules duales contenant un derive peroxydique.
US9018409B2 (en) * 2010-10-27 2015-04-28 Meurice R&D Asbl Process for functionalization of unsaturated compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT876346E (pt) * 1995-11-16 2002-01-30 Hoffmann La Roche Derivados de quinolina com actividade anti-malaria

Also Published As

Publication number Publication date
ZA200207851B (en) 2004-01-26
AP2002002646A0 (en) 2002-12-31
EP1268470A1 (fr) 2003-01-02
EP1268470B1 (fr) 2008-02-27
NO20024795D0 (no) 2002-10-04
ES2302727T3 (es) 2008-08-01
PT1268470E (pt) 2008-06-05
DE60132981T2 (de) 2009-03-19
KR20020084294A (ko) 2002-11-04
KR100832047B1 (ko) 2008-05-27
NZ521774A (en) 2005-10-28
IS6579A (is) 2002-10-03
WO2001077105A1 (fr) 2001-10-18
MXPA02009856A (es) 2004-02-26
FR2807433B1 (fr) 2002-09-20
AU4846301A (en) 2001-10-23
ATE387441T1 (de) 2008-03-15
HUP0300428A2 (hu) 2003-06-28
AP1399A (en) 2005-04-27
DE60132981D1 (de) 2008-04-10
US7566710B2 (en) 2009-07-28
US6949569B2 (en) 2005-09-27
AU2001248463B2 (en) 2006-03-16
JP2004521855A (ja) 2004-07-22
MY128443A (en) 2007-02-28
BR0109885A (pt) 2003-06-03
US20050288315A1 (en) 2005-12-29
DK1268470T3 (da) 2008-06-30
CN1426410A (zh) 2003-06-25
CY1108071T1 (el) 2014-02-12
FR2807433A1 (fr) 2001-10-12
IL151918A0 (en) 2003-04-10
OA13294A (fr) 2007-04-13
CA2405076C (fr) 2012-03-20
IL151918A (en) 2010-04-29
US20040038957A1 (en) 2004-02-26
AR041773A1 (es) 2005-06-01
NO20024795L (no) 2002-12-06
HK1056882A1 (en) 2004-03-05
CA2405076A1 (fr) 2001-10-18
CN1193028C (zh) 2005-03-16

Similar Documents

Publication Publication Date Title
US5576355A (en) Diamondoid derivatives for pharmaceutical use
JP5244083B2 (ja) 病原体不活化のための脆い化合物
RU2267488C2 (ru) Производные акридина, способ их получения и фармацевтическая композиция на их основе
CZ118894A3 (en) Pharmaceutical preparation exhibiting activity against hiv and process for preparing thereof
CN115745830B (zh) 联萘二甲酸衍生物及其制备方法和应用
IL111355A (en) Pharmaceutical preparations containing a history of aminoxoazoline, such new compounds and their preparation
FI93117B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinijohdannaisten valmistamiseksi
KR100416182B1 (ko) 페브리퓨진 및 이소페브리퓨진과 그 제조방법
NO329526B1 (no) Tofunksjonelle molekyler inneholdende et peroksidderivat, fremgangsmate for fremstilling derav, anvendelse derav for fremstilling av antimalariaprodukter, samt farmasoytiske formuleringer som omfatter minst ett slikt koblingsprodukt
WO1994022837A1 (fr) N-METHYLE-N-/α,Δ-GLUCOPYRANOZIL/AMMONIAC-2-/ACRIDON-9-ON-10-YLE/ACETATE/CYCLOPHERONE DOTEE DE PROPRIETES DE PRODUCTION D'INTERFERON, ANTIVIRALES (Y COMPRIS L'ACTIVITE ANTI-VIH), ANTIPARASITAIRES, ANTI-PROMOTEUR ET RADIOPROTECTRICES
US5726203A (en) Qinghaosu derivatives against AIDS
Dallavalle et al. Novel cytotoxic 7-iminomethyl and 7-aminomethyl derivatives of camptothecin
MXPA06005409A (es) Moleculas duales que contienen un derivado peroxidico, su sintesis y sus aplicaciones terapeuticas.
US8022080B2 (en) Small molecules with antiprotozoal activity
JP2003505357A (ja) ビス第４アンモニウム塩の前駆体及び駆虫活性をもつプロドラッグとしてのその応用
JPH02504152A (ja) レニン阻害剤、それらの製法および用途
JP2025531423A (ja) ステロイド又はビタミンを有するポリマー
Abdullah Design, Synthesis, Molecular Docking and Biological Investigation of New Hydroxamic Acid, Amide and Hydrazide Derivatives of Fluoroquinolones
Nyakio Synthesis and antimalarial evaluation of a quinoline-trioxane hybrid drug
TH63693A (th) อนุพันธ์ ไอโซควิโนลีน

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees